Publications

Tebbs VM
Monitoring drugs
Br Med J 1985; 290: 857

Tebbs VM, Martin AJ
Affective disorders in the elderly: 1000 patient GP trial on new drug
Geriatric Medicine 1987; Oct: 17 - 21

Franchimont P, Houben H, Tebbs VM
A double blind study to compare a once daily dose of 1600mg sustained release ibuprofen with standard 400mg ibuprofen tablets given four times daily in patients with osteoarthritis of the knee
Scand J Rheumatol 1990; Suppl 85: 61

Baumgartner H, Scrimshire JA, Tebbs VM
A single blind, parallel group, multiple dose study of the efficacy and tolerability of sustained release ibuprofen and sustained release diclofenac sodium in the treatment of osteoarthritis
Scand J Rheumatol 1990; Suppl 85: 61

Tebbs VM, Muldoon CG, Goulder MA
An open parallel group, multicentre study to assess the comparative efficacy and tolerability of sustained-release ibuprofen (Brufen Retard) and standard ibuprofen
Hung Rheum 1991; 32 (Suppl 1): 360

Azanza JR, Macias HJJ, Tebbs VM
Randomized double-blind clinical trial for investigating the efficacy and tolerance of Flurbiprofen Retard in comparison with tiaprofenic acid in the treatment of active rheumatoid arthritis
Hung Rheum 1991; 32 (Suppl 1): 361

Muldoon CG, Tebbs VM, Munroe AJ
A double-blind clinical trial comparing 24 hour control of arthralgia with sustained-release ibuprofen (Brufen Retard) and piroxicam in elderly patients with osteoarthritis of the hip or knee
Hung Rheum 1991; 32 (Suppl 1): 361

Muldoon CG, Tebbs VM, Goulder MA
An open comparison of a once daily dosage of sustained-release ibuprofen (Brufen Retard) versus standard ibuprofen to assess short and long term tolerability in the elderly
Hung Rheum 1991; 32 (Suppl 1): 362

Haanen HCM, Jacobs PJC, Schardijn GHC, Nayer J De, Hauwaert C, Vanderstraeten G, Vlottes PW, Tebbs VM
Efficacy and tolerability of sustained-release flurbiprofen (Froben Retard, Froben Suscap) in arthritis: hospital based studies in Belgium and Holland
Br J Rheumatol 1992; 31 (Suppl 2): 159

Sanz Frutos P, Moreno E, Tebbs VM
Therapeutic activity and tolerability of sustained-release flurbiprofen (Froben SR) and piroxicam in osteoarthritis of the knee
Br J Rheumatol 1992; 31 (Suppl 2): 160

Flavell Matts SG, Hazelman BL, Houben H, Dhondt E, Tebbs VM
Controlled study of once-daily, sustained-release ibuprofen in osteoarthritis
Curr Therap Res 1993; 53: 394 – 400

Aspinall P, Clark R, Kell P, Holder M, Miles K, Kinghorn G, Herman S, Bradbury C, Tebbs V
Quality of life of women with diagnosed bacterial vaginosis (BV)
International Journal of Gynecology and Obstetrics 1999;67:S44

Jenkins D, Tebbs VM, Seth R
Prospective study of p16 in immunohistochemistry in routine diagnosis of cervical intraepithelial neoplasia
Abstract presented at the Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain and Ireland, Liverpool, 3rd – 6th July 2001

Jenkins D, Tebbs VM, Seth R
Prospective study of p16INK4a immunohistochemistry for the diagnosis of cervical intraepithelial neoplasia in cervical biopsies
Abstract presented at 19th International Papillomavirus Conference, Florianopolis Brazil, 1st – 7th Sep 2001

Gollnick H, Guillén Barona C, Frank RGJ, Ruzicka T, Megahed M, Haynes I, Tebbs V, Hawkinson R
Clinical efficacy of imiquimod 5% cream in the treatment of superficial basal cell carcinoma: initial results from an ongoing, long-term five years follow-up study in Europe
Abstract presented at 9th World Congress on Cancers of the Skin 7-10 May, 2003, Seville, Spain

Gollnick H, Guillén Barona C, Frank RGJ, Ruzicka T, Megahed M, Haynes I, Tebbs V, Hawkinson R
Clinical efficacy of imiquimod 5% cream in the treatment of superficial basal cell carcinoma: initial results from an ongoing, long-term five years follow-up study in Europe
Abstract presented at 12th Congress of the European Academy of Dermatology and Venereology, 15 – 18 October, 2003, Barcelona, Spain.

Gollnick H, Guillen Barona C, Frank R, Ruzicka T, Megahed M, Haynes I, Tebbs V, Hawkinson R
Efficacy by clinical evaluation of imiquimod 5% cream in the treatment of superficial basal cell carcinoma: initial results from an ongoing, long-term follow-up study in Europe
Abstract P480 presented at American Academy of Dermatology 62nd Annual Meeting, Washington, DC, US, Feb 6-11 2004

Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrándiz C, Garcia Diez A, Tebbs V, McRae S
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe
Br J Dermatol 2005;152:939–947

Tebbs V, Eedy D
William Wallace and his introduction of Hydriodate of Potash in the 19th century as an effective treatment for syphilis
Abstract presented at BAD 85th Annual Meeting, 4- 7 July 2005, Glasgow
Br J Dermatol 2005;153, Suppl 1: 53 [Abstract H-5]

Gollnick H, Barona CG, Frank RG, Ruzicka T, Megahed M, Tebbs V, Owens M, Stampone P
Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe.
Eur J Dermatol. 2005 Sep-Oct;15(5):374-81

Gollnick H, Guillén Barona C, Frank RGJ, Ruzicka T, Megahed M, Haynes I, Tebbs V, Stampone P
3-Year Recurrence Rates of Superficial Basal Cell Carcinomas after Treatment with Imiquimod 5x/week for 6 weeks
Abstract P1902 presented at American Academy of Dermatology Summer Meeting, San Diego, CA, US, July 26-30 2006

Gollnick H, Guillén Barona C, Frank RGJ, Ruzicka T, Megahed M, Haynes I, Tebbs V, Stampone P
Recurrence rates of superficial basal cell carcinomas 3 years after treatment with imiquimod 5x/week for 6 weeks
Abstract presented at 15th Congress of the European Academy of Dermatology and Venereology, 4 – 8 Oct, 2006, Rhodes, Greece

Dummer R, Hauschild A, Becker JC, Grob JJ, Schadendorf D, Tebbs V, Skalsky J, Kaehler KC, Moosbauer S, Clark R, Meng TC, Urosevic M.
An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma.
Clin Cancer Res. 2008 Feb 1;14(3):856-64

Paul C, Stadler JF, Thaci B, Vincendon P, Kielar D & Tebbs V
Comparison of patient satisfaction for 2 different etanercept delivery systems in psoriasis
Abstract presented at 7th EADV Spring Symposium, 13-16 May 2010, Cavtat, Croatia

Paul C, Stalder J F, Goujon Henry C, Bedane C, Lahfa M, Bernard P, Brault Y, Thaci D, Vincendon P, Kielar D, Tebbs V
Evaluation de la satisfaction des patients concernant les dispositifs d’injection d’etanercept au cours du traitement du psoriasis par biothérapie: une étude randomisée comparant un stylo auto-injecteur et une seringue préremplie
Abstract C131 presented at the Journeés Dermatologiques de Paris, 7-11 Dec 2010, Paris